(S)-nicotine increases expression ISO UGP2 (Homo sapiens) 6480464 Nicotine results in increased expression of UGP2 mRNA CTD PMID:18247414 1,2-dimethylhydrazine multiple interactions ISO Ugp2 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UGP2 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO Ugp2 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of UGP2 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression ISO Ugp2 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of UGP2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO Ugp2 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UGP2 mRNA CTD PMID:17942748 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of UGP2 mRNA CTD PMID:32145629 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:21394737 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Ugp2 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UGP2 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of UGP2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Ugp2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of UGP2 mRNA CTD PMID:21570461 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of UGP2 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Ugp2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of UGP2 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Ugp2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of UGP2 mRNA CTD PMID:19465110 2-methylcholine affects expression ISO UGP2 (Homo sapiens) 6480464 beta-methylcholine affects the expression of UGP2 mRNA CTD PMID:21179406 2-naphthylamine increases expression ISO UGP2 (Homo sapiens) 6480464 2-Naphthylamine results in increased expression of UGP2 mRNA CTD PMID:18247414 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of UGP2 protein CTD PMID:34915118 3-phenylprop-2-enal increases expression ISO UGP2 (Homo sapiens) 6480464 cinnamaldehyde results in increased expression of UGP2 mRNA CTD PMID:17178418 4,4'-diaminodiphenylmethane decreases expression ISO Ugp2 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of UGP2 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO UGP2 (Homo sapiens) 6480464 bisphenol S results in increased expression of UGP2 protein CTD PMID:34186270 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2 and 6-dinitrotoluene affects the expression of UGP2 mRNA CTD PMID:21346803 5-aza-2'-deoxycytidine affects expression ISO UGP2 (Homo sapiens) 6480464 Decitabine affects the expression of UGP2 mRNA CTD PMID:23300844 5-aza-2'-deoxycytidine multiple interactions ISO UGP2 (Homo sapiens) 6480464 Decitabine inhibits the reaction [Smoke results in decreased expression of UGP2 mRNA] CTD PMID:21095227 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of UGP2 mRNA CTD PMID:31881176 acrolein multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of UGP2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of UGP2 mRNA CTD PMID:32699268 aflatoxin B1 decreases expression ISO Ugp2 (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of UGP2 mRNA CTD PMID:19770486 all-trans-retinoic acid increases expression ISO UGP2 (Homo sapiens) 6480464 Tretinoin results in increased expression of UGP2 mRNA CTD PMID:33167477 alpha-pinene multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of UGP2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of UGP2 mRNA CTD PMID:32699268 aristolochic acid A increases expression ISO UGP2 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of UGP2 protein CTD PMID:33212167 aristolochic acid A decreases expression ISO UGP2 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of UGP2 mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO UGP2 (Homo sapiens) 6480464 arsenite promotes the reaction [G3BP1 protein binds to UGP2 mRNA] CTD PMID:32406909 benzo[a]pyrene increases expression ISO UGP2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of UGP2 mRNA CTD PMID:18247414 benzo[a]pyrene decreases expression ISO Ugp2 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of UGP2 mRNA CTD PMID:19770486 bis(2-ethylhexyl) phthalate decreases expression ISO Ugp2 (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of UGP2 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate multiple interactions ISO Ugp2 (Mus musculus) 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of UGP2 mRNA] CTD PMID:19850644 bisphenol A increases expression ISO Ugp2 (Mus musculus) 6480464 bisphenol A results in increased expression of UGP2 mRNA CTD PMID:26063408 bisphenol A decreases expression ISO UGP2 (Homo sapiens) 6480464 bisphenol A results in decreased expression of UGP2 protein CTD PMID:34186270 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of UGP2 mRNA CTD PMID:32145629 and PMID:34947998 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of UGP2 mRNA CTD PMID:30903817 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of UGP2 mRNA CTD PMID:25181051 Bisphenol B increases expression ISO UGP2 (Homo sapiens) 6480464 bisphenol B results in increased expression of UGP2 protein CTD PMID:34186270 Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of UGP2 protein CTD PMID:28903499 cadmium atom multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UGP2 mRNA CTD PMID:35301059 cadmium dichloride increases expression ISO UGP2 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of UGP2 protein CTD PMID:24527689 cadmium dichloride multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UGP2 mRNA CTD PMID:35301059 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of UGP2 mRNA CTD PMID:25993096 carbon nanotube decreases expression ISO Ugp2 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 chenodeoxycholic acid multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of UGP2 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of UGP2 mRNA CTD PMID:33819548 chlorpyrifos decreases expression ISO Ugp2 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of UGP2 mRNA CTD PMID:37019170 cisplatin affects expression ISO UGP2 (Homo sapiens) 6480464 Cisplatin affects the expression of UGP2 mRNA CTD PMID:23300844 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of UGP2 protein CTD PMID:16470657 clofibrate decreases expression ISO Ugp2 (Mus musculus) 6480464 Clofibrate results in decreased expression of UGP2 mRNA CTD PMID:23811191 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of UGP2 mRNA CTD PMID:17602206 copper(II) sulfate decreases expression ISO UGP2 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of UGP2 mRNA CTD PMID:19549813 crocidolite asbestos affects expression ISO UGP2 (Homo sapiens) 6480464 Asbestos and Crocidolite affects the expression of UGP2 mRNA CTD PMID:24160326 cyclosporin A decreases expression ISO Ugp2 (Mus musculus) 6480464 Cyclosporine results in decreased expression of UGP2 mRNA CTD PMID:19770486 cyclosporin A multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of UGP2 mRNA CTD PMID:33819548 cyclosporin A increases expression ISO UGP2 (Homo sapiens) 6480464 Cyclosporine results in increased expression of UGP2 mRNA CTD PMID:25562108 deoxycholic acid multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of UGP2 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of UGP2 mRNA CTD PMID:33819548 dexamethasone increases expression ISO UGP2 (Homo sapiens) 6480464 Dexamethasone results in increased expression of UGP2 mRNA CTD PMID:25047013 dibutyl phthalate decreases expression ISO Ugp2 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of UGP2 mRNA CTD PMID:21266533 dichlorvos decreases activity EXP 6480464 Dichlorvos results in decreased activity of UGP2 protein CTD PMID:222008 dicrotophos decreases expression ISO UGP2 (Homo sapiens) 6480464 dicrotophos results in decreased expression of UGP2 mRNA CTD PMID:28302478 dorsomorphin multiple interactions ISO UGP2 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 ellagic acid decreases expression ISO UGP2 (Homo sapiens) 6480464 Ellagic Acid results in decreased expression of UGP2 mRNA CTD PMID:12002526 entinostat increases expression ISO UGP2 (Homo sapiens) 6480464 entinostat results in increased expression of UGP2 mRNA CTD PMID:26272509 entinostat multiple interactions ISO UGP2 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UGP2 mRNA CTD PMID:27188386 ethanol affects expression ISO Ugp2 (Mus musculus) 6480464 Ethanol affects the expression of UGP2 mRNA CTD PMID:30319688 flucloxacillin affects binding ISO UGP2 (Homo sapiens) 6480464 Floxacillin binds to UGP2 protein CTD PMID:36782357 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of UGP2 mRNA CTD PMID:24793618 folic acid multiple interactions ISO Ugp2 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UGP2 mRNA CTD PMID:22206623 FR900359 increases phosphorylation ISO UGP2 (Homo sapiens) 6480464 FR900359 results in increased phosphorylation of UGP2 protein CTD PMID:37730182 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of UGP2 mRNA CTD PMID:22061828 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of UGP2 mRNA CTD PMID:24136188 glycochenodeoxycholic acid multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of UGP2 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of UGP2 mRNA CTD PMID:33819548 glycocholic acid multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of UGP2 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of UGP2 mRNA CTD PMID:33819548 glycodeoxycholic acid multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of UGP2 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of UGP2 mRNA CTD PMID:33819548 haloperidol increases expression ISO UGP2 (Homo sapiens) 6480464 Haloperidol results in increased expression of UGP2 protein CTD PMID:34122009 ivermectin affects expression ISO UGP2 (Homo sapiens) 6480464 Ivermectin affects the expression of UGP2 protein CTD PMID:32959892 microcystin-LR increases expression ISO Ugp2 (Mus musculus) 6480464 cyanoginosin LR results in increased expression of UGP2 mRNA CTD PMID:17654400 N-methylformamide increases expression ISO Ugp2 (Mus musculus) 6480464 methylformamide analog results in increased expression of UGP2 mRNA and methylformamide results in increased expression of UGP2 mRNA CTD PMID:17040096 N-nitrosodiethylamine multiple interactions EXP 6480464 [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of UGP2 protein CTD PMID:20935162 nicotine increases expression ISO UGP2 (Homo sapiens) 6480464 Nicotine results in increased expression of UGP2 mRNA CTD PMID:18247414 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of UGP2 mRNA CTD PMID:33484710 obeticholic acid increases expression ISO UGP2 (Homo sapiens) 6480464 obeticholic acid results in increased expression of UGP2 mRNA CTD PMID:27939613 ozone multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of UGP2 mRNA more ... CTD PMID:32699268 and PMID:35430440 paracetamol decreases expression ISO UGP2 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of UGP2 mRNA CTD PMID:21420995 and PMID:29067470 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of UGP2 mRNA CTD PMID:33387578 paracetamol multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of UGP2 mRNA CTD PMID:33819548 perfluorohexanesulfonic acid increases expression ISO Ugp2 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of UGP2 mRNA CTD PMID:37995155 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of UGP2 protein CTD PMID:34958885 phenobarbital multiple interactions EXP 6480464 [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of UGP2 protein CTD PMID:20935162 pirinixic acid multiple interactions ISO Ugp2 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of UGP2 mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO Ugp2 (Mus musculus) 6480464 pirinixic acid results in decreased expression of UGP2 mRNA CTD PMID:18445702 more ... quercetin decreases expression ISO UGP2 (Homo sapiens) 6480464 Quercetin results in decreased expression of UGP2 mRNA CTD PMID:21632981 resveratrol decreases expression ISO UGP2 (Homo sapiens) 6480464 resveratrol results in decreased expression of UGP2 mRNA CTD PMID:12002526 resveratrol multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of UGP2 mRNA CTD PMID:23557933 SB 431542 multiple interactions ISO UGP2 (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:37664457 serpentine asbestos affects expression ISO UGP2 (Homo sapiens) 6480464 Asbestos and Serpentine affects the expression of UGP2 mRNA CTD PMID:24160326 sodium arsenate increases expression ISO Ugp2 (Mus musculus) 6480464 sodium arsenate results in increased expression of UGP2 mRNA CTD PMID:21795629 sodium arsenate decreases expression ISO Ugp2 (Mus musculus) 6480464 sodium arsenate results in decreased expression of UGP2 mRNA CTD PMID:30953684 sunitinib decreases expression ISO UGP2 (Homo sapiens) 6480464 Sunitinib results in decreased expression of UGP2 mRNA CTD PMID:31533062 tanespimycin decreases expression ISO UGP2 (Homo sapiens) 6480464 tanespimycin results in decreased expression of UGP2 protein CTD PMID:31370342 tetrachloromethane affects expression ISO Ugp2 (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of UGP2 mRNA CTD PMID:17484886 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of UGP2 mRNA CTD PMID:34492290 trichostatin A decreases expression ISO UGP2 (Homo sapiens) 6480464 trichostatin A results in decreased expression of UGP2 mRNA CTD PMID:24935251 trichostatin A increases expression ISO UGP2 (Homo sapiens) 6480464 trichostatin A results in increased expression of UGP2 mRNA CTD PMID:24935251 triclosan decreases expression ISO UGP2 (Homo sapiens) 6480464 Triclosan results in decreased expression of UGP2 mRNA CTD PMID:30510588 troglitazone decreases expression ISO Ugp2 (Mus musculus) 6480464 troglitazone results in decreased expression of UGP2 mRNA CTD PMID:28973697 valproic acid affects expression ISO Ugp2 (Mus musculus) 6480464 Valproic Acid affects the expression of UGP2 mRNA CTD PMID:17963808 valproic acid multiple interactions ISO UGP2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UGP2 mRNA CTD PMID:27188386 valproic acid affects expression ISO UGP2 (Homo sapiens) 6480464 Valproic Acid affects the expression of UGP2 mRNA CTD PMID:25979313 valproic acid decreases expression ISO UGP2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of UGP2 mRNA CTD PMID:24935251 vancomycin increases expression ISO Ugp2 (Mus musculus) 6480464 Vancomycin results in increased expression of UGP2 mRNA CTD PMID:18930951 vanillin increases expression ISO UGP2 (Homo sapiens) 6480464 vanillin results in increased expression of UGP2 mRNA CTD PMID:17178418 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of UGP2 mRNA CTD PMID:23034163 more ...